Tue Jan 27 16:19:31 SGT 2015  
SINGAPORE
GENITAL™
    Genital warts treatment, Singapore (SG)
HIV STD TESTING SINGAPORE™

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™

Summary

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™ @singaporegenital_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital warts treatment, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
Tue, 27 Jan 2015 00:25:03 +0100 | Oncotarget
Authors: Liekens S, Noppen S, Gijsbers S, Sienaert R, Ronca R, Tobia C, Presta M

Clinical Performance of Hybrid Capture 2 Human Papillomavirus Testing for Recurrent High-Grade Cervical/Vaginal Intraepithelial Neoplasm in Patients With an ASC-US Papanicolaou Test Result During Long-Term Posttherapy Follow-up Monitoring.
Mon, 26 Jan 2015 17:00:11 +0100 | Archives of Pathology and Laboratory Medicine
Conclusion s.- HC2 yielded a false-negative rate of 8% for CIN 3. HC2 testing therefore may not be sufficient for triage of patients with an ASC-US Papanicolaou test result. Patients with ASC-US during long-term posttherapy follow-up need close monitoring, with colposcopic evaluation if clinically indicated.

Cervista HPV HR Test for Cervical Cancer Screening: A Comparative Study in the Catalonian Population.
Mon, 26 Jan 2015 17:00:09 +0100 | Archives of Pathology and Laboratory Medicine
Conclusions .- Our results demonstrate that the Cervista HPV HR test shows the same specificity as the HC2 assay. We therefore conclude that the Cervista HPV HR test is suitable for cervical cancer screening purposes.

Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPVā€positive oropharyngeal squamous cell carcinoma
Mon, 26 Jan 2015 00:00:00 +0100 | Cancer Medicine
Abstract

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mon, 26 Jan 2015 00:00:00 +0100 | Cancer Medicine
We describe our experience with the disorder in three affected families and a comprehensive review of current literature.

Low Human Papillomavirus (HPV) Vaccine Knowledge Among Latino Parents in Utah
Sun, 25 Jan 2015 07:03:21 +0100 | Journal of Immigrant and Minority Health
Abstract

Exploring the Role of Ethnic Identity on the Attitudes Towards HPV Vaccine Advertising Among Puerto Ricans: A Qualitative Analysis
Sun, 25 Jan 2015 07:03:03 +0100 | Journal of Immigrant and Minority Health
Abstract

Sexually Transmitted Diseases
Sat, 24 Jan 2015 05:22:19 +0100 | Clinical Obstetrics and Gynecology
Sexually transmitted diseases (STDs) continue to be a global epidemic with significant risk of morbidity/mortality for the fetus. STDs with prominent cutaneous findings including condylomata acuminata, genital herpes infections, and syphilis are reviewed. Important clinical cutaneous findings help aid early diagnosis and facilitate treatment. Condylomata acuminata have the potential of causing cervical cancer, anogenital cancer, and oropharyngeal cancer. Significant advances have been made in human papilloma virus vaccinations and treatment. Genital herpes infection can produce significant physical and emotional distress to the patient and significant potential harm to the fetus. Early clinical recognition of STDs and their appropriate management is critical. (Source: Clinical Obstetrics a...

Two-Dose HPV Vaccine Approach Cost-effective for Girls Under 15Two-Dose HPV Vaccine Approach Cost-effective for Girls Under 15
Fri, 23 Jan 2015 20:47:53 +0100 | Medscape Pediatrics Headlines
Giving girls younger than 15 two doses of the human papillomavirus (HPV) vaccine, at least six months apart, will probably provide adequate protection against cervical cancer while also being cost-effective, according to new findings published online January 7 in the BMJ. Reuters Health Information (Source: Medscape Pediatrics Headlines)

Correlates of Human Papillomavirus Vaccine Coverage: A State-Level Analysis
Fri, 23 Jan 2015 20:21:24 +0100 | Sexually Transmitted Diseases
Conclusions: Human papillomavirus vaccine coverage for girls was lower in states with higher HPV-related cancer rates. Public health efforts should concentrate on geographic areas with higher cancer rates. Strengthening adolescent preventive health care use may be particularly important to increase vaccine follow-through. Cost-effectiveness analyses may overestimate the benefits of current vaccination coverage and underestimate the benefits of increasing coverage. (Source: Sexually Transmitted Diseases)